The yin and yang of human soil-transmitted helminth infections
- PMID: 34774540
 - PMCID: PMC9145206
 - DOI: 10.1016/j.ijpara.2021.11.001
 
The yin and yang of human soil-transmitted helminth infections
Abstract
The major soil-transmitted helminths that infect humans are the roundworms, whipworms and hookworms. Soil-transmitted helminth infections rank among the most important neglected tropical diseases in terms of morbidity, and almost one billion people are still infected with at least one species. While anthelmintic drugs are available, they do not offer long term protection against reinfection, precipitating the need for vaccines that provide long-term immunologic defense. Vaccine discovery and development is in advanced clinical development for hookworm infection, with a bivalent human hookworm vaccine in clinical trials in Brazil and Africa, but is in its infancy for both roundworm (ascariasis) and whipworm (trichuriasis) infections. One of the greatest hurdles to developing soil-transmitted helminth vaccines is the potent immunoregulatory properties of these helminths, creating a barrier to the induction of meaningful long-term protective immunity. While challenging for vaccinologists, this phenomenon presents unique opportunities to develop an entirely new class of anti-inflammatory drugs that capitalise on these immunomodulatory strategies. Epidemiologic studies and clinical trials employing experimental soil-transmitted helminth challenge models, when coupled with findings from animal models, show that at least some soil-transmitted helminth-derived molecules can protect against the onset of autoimmune, allergic and metabolic disorders, and several natural products with the desired bioactivity have been isolated and tested in pre-clinical settings. The yin and yang of soil-transmitted helminth infections reflect both the urgency for effective vaccines and the potential for new immunoregulatory molecules from parasite products.
Keywords: Ascaris; Hookworm; Immunomodulation; Inflammation; Soil-transmitted helminth; Vaccine; Whipworm.
Copyright © 2021 Australian Society for Parasitology. Published by Elsevier Ltd. All rights reserved.
Figures
References
- 
    
- Adegnika AA, de Vries SG, Zinsou FJ, Honkepehedji YJ, Dejon Agobé J-C, Vodonou KG, Bikangui R, Bouyoukou Hounkpatin A, Bache EB, Massinga Loembe M, van Leeuwen R, Molemans M, Kremsner PG, Yazdanbakhsh M, Hotez PJ, Bottazzi ME, Li G, Bethony JM, Diemert DJ, Grobusch MP, Mouwenda YD, Betouke Ongwe E, Nkoma Mouima A-M, Nouatin OP, Edoa JR, Manouana PG, Pinto de Jesus S, Kühne V, Mordmueller B, Lell B, Agnandji ST, Koehler C, 2021. Safety and immunogenicity of co-administered hookworm vaccine candidates Na-GST-1 and Na-APR-1 in Gabonese adults: a randomised, controlled, double-blind, phase 1 dose-escalation trial. Lancet Infect. Dis 21, 275–285. 10.1016/S1473-3099(20)30288-7. - DOI - PubMed
 
 - 
    
- Ásbjörnsdóttir KH, Ajjampur SSR, Anderson RM, Bailey R, Gardiner I, Halliday KE, Ibikounle M, Kalua K, Kang G, Littlewood DTJ, Luty AJF, Means AR, Oswald W, Pullan RL, Sarkar R, Schär F, Szpiro A, Truscott JE, Werkman M, Yard E, Walson JL, Garba A, 2018. Assessing the feasibility of interrupting the transmission of soil-transmitted helminths through mass drug administration: The DeWorm3 cluster randomized trial protocol. PLOS Neglect. Trop. Dis 12, e0006166. 10.1371/journal.pntd.0006166. - DOI - PMC - PubMed
 
 
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
              
              